Overview
At Innovative Biotech Solutions, we are pioneering the development of personalized biopharmaceutical therapies aimed at treating complex diseases such as cancer and autoimmune disorders. Our approach leverages advanced genomics and machine learning to tailor treatments to individual patients, significantly enhancing efficacy and reducing side effects compared to traditional therapies. Since our inception in 2024, we have successfully completed preclinical trials for our lead candidate, which demonstrated promising results in targeting specific biomarkers. Our team comprises seasoned professionals from top biotech firms and research institutions, combined with a dedicated technical team focused on optimizing our platform. Investment is crucial for us now to transition from preclinical to clinical trial phases, ensuring we can deliver on our mission to transform patient care through precision medicine. Looking for an investor who understands the market and can support practical growth. Development of personalized biopharmaceutical therapies leveraging genomics and AI.
Use of funds
The requested investment of $32,000 will be allocated as follows: 40% for clinical trial preparation and execution, 30% for laboratory equipment and materials, and 30% for hiring additional research personnel to accelerate R&D efforts.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.